CA Stock MarketDetailed Quotes

Restart Life Sciences Corp (HEAL)

Watchlist
  • 0.090
  • 0.0000.00%
15min DelayMarket Closed May 12 14:09 ET
5.34MMarket Cap-2.25P/E (TTM)

Restart Life Sciences Corp (HEAL) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-899.29%-717.22K
-2,781.68%-325.52K
-1,672.67%-78.87K
-694.90%-77.59K
-408.46%-235.25K
74.14%-71.77K
30.92%-11.3K
-163.57%-4.45K
89.88%-9.76K
73.05%-46.27K
Net income from continuing operations
-718.72%-1.39M
-115,779.41%-157.32K
-145.91%-210.99K
-124.65%-203.48K
-467.08%-818.75K
118.36%224.75K
100.06%136
349.68%459.57K
70.09%-90.58K
72.66%-144.38K
Operating gains losses
112.06%105.11K
46.46%-159.11K
--44.76K
--48.34K
--171.13K
---871.86K
---297.19K
----
----
----
Depreciation and amortization
-19.95%1.85K
-17.47%477
-20.93%457
-20.62%458
-20.76%458
-21.42%2.31K
-21.36%578
-21.47%578
-21.50%577
-21.36%578
Remuneration paid in stock
1,232.65%431.53K
-100.00%-1
--0
--0
--431.53K
-88.16%32.38K
--32.38K
--0
--0
--0
Other non cashItems
52.49%401.56K
--402.44K
--0
--0
---882
229.17%263.34K
----
----
----
----
Change In working capital
-196.18%-266.73K
-3,811.09%-411.99K
-21.05%86.91K
-3.93%77.09K
-119.20%-18.73K
-53.04%277.32K
-105.47%-10.53K
-42.16%110.08K
-60.97%80.24K
4,301.35%97.53K
-Change in receivables
190.03%3.96K
90.41%-552
110.71%167
203.72%10.36K
-1,100.00%-6.01K
-661.48%-4.4K
-3,695.63%-5.75K
-164.64%-1.56K
929.93%3.41K
63.62%-501
-Change in prepaid assets
-2,265.44%-100K
---100K
--0
--0
--0
29.36%4.62K
--0
--0
--0
105.47%4.62K
-Change in payables and accrued expense
-161.60%-170.69K
-6,414.16%-311.44K
-22.30%86.74K
-13.15%66.73K
-113.61%-12.72K
-52.73%277.1K
-102.56%-4.78K
-36.74%111.64K
-43.09%76.83K
6.14%93.42K
Cash from discontinued investing activities
Operating cash flow
-899.29%-717.22K
-2,781.68%-325.52K
-1,672.67%-78.87K
-694.90%-77.59K
-408.46%-235.25K
74.14%-71.77K
30.92%-11.3K
-163.57%-4.45K
89.88%-9.76K
73.05%-46.27K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
2,973.27%2.3M
12,153.35%1.84M
0
0
678.25%466.95K
292.67%75K
15K
0
0
214.14%60K
Net issuance payments of debt
122.60%166.95K
1,566.67%250K
--0
--0
-238.42%-83.05K
--75K
--15K
--0
--0
--60K
Net common stock issuance
--1.66M
--1.11M
--0
--0
--550K
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
--474.8K
----
----
----
----
--0
--0
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
2,973.27%2.3M
12,153.35%1.84M
--0
--0
678.25%466.95K
292.67%75K
--15K
--0
--0
214.14%60K
Net cash flow
Beginning cash position
39.90%11.32K
1,037.33%86.56K
1,271.71%165.43K
1,013.69%243.02K
39.90%11.32K
-96.97%8.09K
-68.86%7.61K
-30.86%12.06K
-80.85%21.82K
-96.97%8.09K
Current changes in cash
49,101.55%1.59M
40,733.88%1.51M
-1,672.67%-78.87K
-694.90%-77.59K
1,587.20%231.7K
101.25%3.23K
122.65%3.7K
-163.57%-4.45K
89.88%-9.76K
109.00%13.73K
End cash Position
14,032.12%1.6M
14,032.12%1.6M
1,037.33%86.56K
1,271.71%165.43K
1,013.69%243.02K
39.90%11.32K
39.90%11.32K
-68.86%7.61K
-30.86%12.06K
-80.85%21.82K
Free cash from
-899.29%-717.22K
-2,781.68%-325.52K
-1,672.67%-78.87K
-694.90%-77.59K
-408.46%-235.25K
74.14%-71.77K
30.92%-11.3K
-163.57%-4.45K
89.88%-9.76K
73.05%-46.27K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -899.29%-717.22K-2,781.68%-325.52K-1,672.67%-78.87K-694.90%-77.59K-408.46%-235.25K74.14%-71.77K30.92%-11.3K-163.57%-4.45K89.88%-9.76K73.05%-46.27K
Net income from continuing operations -718.72%-1.39M-115,779.41%-157.32K-145.91%-210.99K-124.65%-203.48K-467.08%-818.75K118.36%224.75K100.06%136349.68%459.57K70.09%-90.58K72.66%-144.38K
Operating gains losses 112.06%105.11K46.46%-159.11K--44.76K--48.34K--171.13K---871.86K---297.19K------------
Depreciation and amortization -19.95%1.85K-17.47%477-20.93%457-20.62%458-20.76%458-21.42%2.31K-21.36%578-21.47%578-21.50%577-21.36%578
Remuneration paid in stock 1,232.65%431.53K-100.00%-1--0--0--431.53K-88.16%32.38K--32.38K--0--0--0
Other non cashItems 52.49%401.56K--402.44K--0--0---882229.17%263.34K----------------
Change In working capital -196.18%-266.73K-3,811.09%-411.99K-21.05%86.91K-3.93%77.09K-119.20%-18.73K-53.04%277.32K-105.47%-10.53K-42.16%110.08K-60.97%80.24K4,301.35%97.53K
-Change in receivables 190.03%3.96K90.41%-552110.71%167203.72%10.36K-1,100.00%-6.01K-661.48%-4.4K-3,695.63%-5.75K-164.64%-1.56K929.93%3.41K63.62%-501
-Change in prepaid assets -2,265.44%-100K---100K--0--0--029.36%4.62K--0--0--0105.47%4.62K
-Change in payables and accrued expense -161.60%-170.69K-6,414.16%-311.44K-22.30%86.74K-13.15%66.73K-113.61%-12.72K-52.73%277.1K-102.56%-4.78K-36.74%111.64K-43.09%76.83K6.14%93.42K
Cash from discontinued investing activities
Operating cash flow -899.29%-717.22K-2,781.68%-325.52K-1,672.67%-78.87K-694.90%-77.59K-408.46%-235.25K74.14%-71.77K30.92%-11.3K-163.57%-4.45K89.88%-9.76K73.05%-46.27K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 2,973.27%2.3M12,153.35%1.84M00678.25%466.95K292.67%75K15K00214.14%60K
Net issuance payments of debt 122.60%166.95K1,566.67%250K--0--0-238.42%-83.05K--75K--15K--0--0--60K
Net common stock issuance --1.66M--1.11M--0--0--550K--0--0--0--0--0
Proceeds from stock option exercised by employees --474.8K------------------0--0--0--0--0
Cash from discontinued financing activities
Financing cash flow 2,973.27%2.3M12,153.35%1.84M--0--0678.25%466.95K292.67%75K--15K--0--0214.14%60K
Net cash flow
Beginning cash position 39.90%11.32K1,037.33%86.56K1,271.71%165.43K1,013.69%243.02K39.90%11.32K-96.97%8.09K-68.86%7.61K-30.86%12.06K-80.85%21.82K-96.97%8.09K
Current changes in cash 49,101.55%1.59M40,733.88%1.51M-1,672.67%-78.87K-694.90%-77.59K1,587.20%231.7K101.25%3.23K122.65%3.7K-163.57%-4.45K89.88%-9.76K109.00%13.73K
End cash Position 14,032.12%1.6M14,032.12%1.6M1,037.33%86.56K1,271.71%165.43K1,013.69%243.02K39.90%11.32K39.90%11.32K-68.86%7.61K-30.86%12.06K-80.85%21.82K
Free cash from -899.29%-717.22K-2,781.68%-325.52K-1,672.67%-78.87K-694.90%-77.59K-408.46%-235.25K74.14%-71.77K30.92%-11.3K-163.57%-4.45K89.88%-9.76K73.05%-46.27K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More